PF-05085727 | Interleukin Related interleukin-related.com

Product Name :
PF-05085727

Search keywords :
PF-05085727

drugId :
null

Target Vo:
Phosphodiesterase 2A

Target Vo Short Name :
PDE2A

Moa_Name:
Phosphodiesterase 2A inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Pfizer Inc

Active Indication_Name:
Cognition Disorders

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-NF-KB p65 (Thr254) Antibody
Dynamin 1 Antibody
NR1H4 Antibody: NR1H4 Antibody is an unconjugated, approximately 56 kDa, rabbit-derived, anti-NR1H4 polyclonal antibody. NR1H4 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, sheep background without labeling.

Author: Interleukin Related

Related Posts